Dolby Laboratories
Last updated September 27, 2026
Organization details
- Legal name
- Dolby Laboratories
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- DLB
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001308547
Board of directors
-
Anjali Sud · DirectorSince 2023
-
Avadis Tevanian · DirectorSince 2023
-
David Dolby · DirectorSince 2023
-
Emily Rollins · DirectorSince 2023
-
Kevin J. Yeaman · Director · President and CEOSince 2023
-
Micheline Chau · DirectorSince 2023
-
Peter C. Gotcher · DirectorSince 2023
-
Simon Segars · DirectorSince 2023
-
Tony A. Prophet · DirectorSince 2023
Chief executives
Kevin J. Yeaman
· President and CEO
Dates unknown
Board connections
3 of this board's directors also sit on 3 other boards.
- via Peter C. Gotcher
- via Micheline Chau
- via Emily Rollins
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2024 | Kevin J. Yeaman Director, Officer (President and CEO) | Open-market purchase | +3 | $78.15 | $200 |
| May 28, 2024 | SHERMAN MARK ANDREW Officer (EVP, Gen. Counsel & Secretary) | Option exercise | +1,998 | $62.32 | $124,515 |
| May 28, 2024 | SHERMAN MARK ANDREW Officer (EVP, Gen. Counsel & Secretary) | Open-market sale | −2,283 | $79.62 | $181,772 |
| May 16, 2024 | Revankar Shriram Officer (SVP, Advanced Technology Group) | Shares withheld for tax | −4,409 | $83.70 | $369,033 |
| May 13, 2024 | Dolby Dagmar 10% owner | Derivative conversion | +415,000 | — | — |
| May 13, 2024 | Dolby Dagmar 10% owner | Gift | −415,000 | — | — |
| Mar 1, 2024 | Emily Rollins Director | Open-market sale | −1,000 | $80.88 | $80,880 |
| Feb 28, 2024 | Pendleton Todd Officer (SVP, Chief Marketing Officer) | Option exercise | +8,499 | $71.07 | $604,024 |
| Feb 28, 2024 | Pendleton Todd Officer (SVP, Chief Marketing Officer) | Option exercise | +3,523 | $68.40 | $240,973 |
| Feb 28, 2024 | Pendleton Todd Officer (SVP, Chief Marketing Officer) | Open-market sale | −24,395 | $81.69 | $1,992,828 |
| Feb 9, 2024 | Couling John D Officer (SVP, Entertainment) | Option exercise | +12,440 | $42.98 | $534,671 |
| Feb 9, 2024 | Couling John D Officer (SVP, Entertainment) | Option exercise | +21,120 | $62.32 | $1,316,198 |
| Feb 9, 2024 | Couling John D Officer (SVP, Entertainment) | Open-market sale | −33,560 | $80.81 | $2,711,984 |
| Feb 8, 2024 | Couling John D Officer (SVP, Entertainment) | Option exercise | +50,000 | $42.98 | $2,149,000 |
| Feb 8, 2024 | Couling John D Officer (SVP, Entertainment) | Open-market sale | −50,000 | $80.00 | $4,000,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.